SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 31.80-0.1%Nov 21 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Cacaito who wrote (4953)12/5/1997 12:29:00 AM
From: aknahow  Read Replies (1) of 17367
 
Cacaito, not my field, but just a thought. If BPI is ever approved and becomes a standard tool for combating endotoxin in meningococcemia would it not be given at almost the same time as an antibiotic? If so would not real life use tend to produce better results than in a trial where bpi is given 4 to 5 hours after antibiotics have already been used?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext